The information below relates to activities of Pops, Inc. in 2019. Pops starts with the following initial partners: William, Lexi, and Megan. Pops develops, manufactures and sells pharmaceuticals. Below are the transactions for the year-ended 12/31/19. Please prepare the necessary journal entries and adjusting journal entries at the end of 2019, for the following transactions assuming all amounts are paid in cash, unless otherwise stated. May 1 Pops purchases 5-year, $ 500,000 par value Cerber Company bonds. The bonds pay interest annually at 6% each December 31 and are dated January 1, 2018. Pops purchased the bonds at a yield of 5%, plus accrued interest. They intend to hold the bonds until they mature. June 25 Orgin delivered 5,000 lbs of the key ingredient as promised. Pops pays for all of it in cash. June 30 Pops receives interest from the Ordeal bonds. July 1 Pops pays $850,000 to Hegar Construction for the production facility. August 1 Pops completes testing of Pillex and determines it is financially viable. They start the process of filing for a patent and incur legal costs of $180,000. August 15 Pops purchases 15,000 shares of Doran, Inc. common stock, with the intent to sell within a year, for $42 per share. The broker's commission on the purchase amounted to $2,000